Peimisine
Peimisine (Ebeiensine) is a research compound with demonstrated bioactivity in models of asthma, acute lung injury, hepatic fibrosis, and hypertension. Its mechanisms include tracheal smooth muscle relaxation via M-receptor modulation and nitric oxide release, as well as protective effects against LPS-induced lung injury and angiotensin-converting enzyme inhibition.
Product Specifications
CAS Number
19773-24-1
Product Name Alternative
MAChR, Muscarinic acetylcholine receptor, muscarinic M receptor, induce apoptosis, LLC, inhibit, HepG2, Inhibitor, ACE, A549, A2780, anti-inflammatory activity, antihypertensive activity, anti-tumor activity, Angiotensin-converting Enzyme (ACE), angiotensin converting enzyme, angiotensin I converting enzyme (ACE1), asthma, cough, Ebeiensine, Peimisine
Field of Research
Cell Biology, Metabolism Research, Neuroscience
Purity
98.99% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.34 mM) ; DMSO:9 mg/mL (21.05 mM)
Smiles
C[C@@H]1[C@@H]2NC[C@@H] (C) C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC (=O) [C@H]4C[C@@H] (O) CC[C@]4 (C) [C@H]3CC2=C1C
Molecular Formula
C27H41NO3
Molecular Weight
427.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
